X-120626501-C-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001011551.3(C1GALT1C1):āc.666G>Cā(p.Gln222His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000315 in 1,210,871 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 175 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001011551.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C1GALT1C1 | NM_001011551.3 | c.666G>C | p.Gln222His | missense_variant | 2/2 | ENST00000304661.6 | |
C1GALT1C1 | NM_152692.5 | c.666G>C | p.Gln222His | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C1GALT1C1 | ENST00000304661.6 | c.666G>C | p.Gln222His | missense_variant | 2/2 | 1 | NM_001011551.3 | P1 | |
C1GALT1C1 | ENST00000371313.2 | c.666G>C | p.Gln222His | missense_variant | 3/3 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000222 AC: 25AN: 112692Hom.: 0 Cov.: 24 AF XY: 0.000230 AC XY: 8AN XY: 34834
GnomAD3 exomes AF: 0.000393 AC: 72AN: 183344Hom.: 0 AF XY: 0.000560 AC XY: 38AN XY: 67820
GnomAD4 exome AF: 0.000325 AC: 357AN: 1098124Hom.: 0 Cov.: 31 AF XY: 0.000459 AC XY: 167AN XY: 363498
GnomAD4 genome AF: 0.000222 AC: 25AN: 112747Hom.: 0 Cov.: 24 AF XY: 0.000229 AC XY: 8AN XY: 34899
ClinVar
Submissions by phenotype
Polyagglutinable erythrocyte syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 14, 2023 | - - |
C1GALT1C1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 23, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at